The effect of cone opsin mutations on retinal structure and the integrity of the photoreceptor mosaic

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 13, 2012, Pages 8006-8015

  Carroll, Joseph ^a   Dubra, Alfredo ^a,b,c   Gardner, Jessica C ^d   Mizrahi Meissonnier, Liliana ^e   Cooper, Robert F ^f   Dubis, Adam M ^a   Nordgren, Rick ^a   Genead, Mohamed ^g,h   Connor, Thomas B ^a   Stepien, Kimberly E ^a   Sharon, Dror ^e   Hunt, David M ^d,i   Banin, Eyal ^e   Hardcastle, Alison J ^d   Moore, Anthony T ^d,j   Williams, David R ^b,c   Fishman, Gerald ^g,h   Neitz, Jay ^k   Neitz, Maureen ^k   Michaelides, Michel ^d,j  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^f Marquette University   (United States)

^g Chicago Lighthouse for People Who Are Blind or Visually Impaired   (United States)

^h UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

ⁱ UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^j MOORFIELDS EYE HOSPITAL   (United Kingdom)

^k UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; GENOTYPE; HUMAN; MALE; MOLECULAR GENETICS; OPN1LW GENE; OPN1MW GENE; PHOTORECEPTOR; PRIORITY JOURNAL; RETINA; RETINA FOVEA; RETINAL THICKNESS; SCANNING LASER OPHTHALMOSCOPE; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL SYSTEM PARAMETERS;

EID: 84873337052     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-11087     Document Type: Article

References (49)

1. Nathans J, Davenport CM, Maumenee IH, et al. Molecular genetics of human blue cone monochromacy. Science. 1989; 245:831-838.
2. Winderickx J, Sanocki E, Lindsey DT, et al. Defective colour vision associated with a missense mutation in the human green visual pigment gene. Nat Genet. 1992;1:251-256.
3. Nathans J, Maumenee IA, Zrenner E, et al. Genetic heterogeneity among blue-cone monochromats. Am J Hum Genet. 1993;53:987-1000.
4. Ayyagari R, Kakuk LE, Toda Y, et al. Blue cone monochromacy: macular degeneration in individuals with cone specific gene loss. In: Hollyfield JG, Anderson RE, LaVail MM, eds. Retinal Degenerative Diseases and Experimental Therapy. New York: Kluwer Academic/Plenum Publishers; 1999.
5. Jagla WM, Jägle H, Hayashi T, et al. The molecular basis of dichromatic color vision in males with multiple red and green visual pigment genes. Hum Mol Genet. 2002;11:23-32.
6. Kellner U, Wissinger B, Tippmann S, et al. Blue cone monochromatism: clinical findings in patients with mutations in the red/green opsin gene cluster. Graefes Arch Clin Exp Ophthalmol. 2004;242:729-735.
7. Neitz M, Carroll J, Renner A, et al. Variety of genotypes in males diagnosed as dichromatic on a conventional clinical anomaloscope. Vis Neurosci. 2004;21:205-216.
8. Carroll J, Neitz M, Hofer H, et al. Functional photoreceptor loss revealed with adaptive optics: an alternate cause for color blindness. Proc Natl Acad Sci U S A. 2004;101:8461-8466.
9. Young TL, Deeb SS, Ronan SM, et al. X-linked high myopia associated with cone dysfunction. Arch Ophthalmol. 2004; 122:897-908.
10. Crognale MA, Fry M, Highsmith J, et al. Characterization of a novel form of X-linked incomplete achromatopsia. Vis Neurosci. 2004;21:197-203.
11. Michaelides M, Johnson S, Bradshaw K, et al. X-linked cone dysfunction syndrome with myopia and protanopia. Ophthalmology. 2005;112:1448-1454.
12. Michaelides M, Johnson S, Simunovic MP, et al. Blue cone monochromatism: a phenotype and genotype assessment with evidence of progressive loss of cone function in older individuals. Eye. 2005;19:2-10.
13. Mizrahi-Meissonnier L, Merin S, Banin E, Sharon D. Variable retinal phenotypes caused by mutations in the X-linked photopigment gene array. Invest Ophthalmol Vis Sci. 2010; 51:3884-3892.
14. Carroll J, Baraas RC, Wagner-Schuman M, et al. Cone photoreceptor mosaic disruption associated with Cys203Arg mutation in the M-cone opsin. Proc Natl Acad Sci U S A. 2009; 106:20948-20953.
15. Gardner JC, Michaelides M, Holder GE, et al. Blue cone monochromacy: causative mutations and associated phenotypes. Mol Vis. 2009;15:876-884.
16. Gardner JC, Webb TR, Kanuga N, et al. X-linked cone dystrophy caused by mutation of the red and green cone opsins. Am J Hum Genet. 2010;87:26-39.
17. Wagner-Schuman M, Neitz J, Rha J, et al. Color-deficient cone mosaics associated with Xq28 opsin mutations: a stop codon versus gene deletions. Vision Res. 2010;50:2396-2402.
18. Rha J, Dubis AM, Wagner-Schuman M, et al. Spectral domain optical coherence tomography and adaptive optics: imaging photoreceptor layer morphology to interpret preclinical phenotypes. Adv Exp Med Biol. 2010;664:309-316.
19. Neitz J, Neitz M. The genetics of normal and defective color vision. Vision Res. 2011;51:633-651.
20. Carroll J, Neitz M, Neitz J. Estimates of L:M cone ratio from ERG flicker photometry and genetics. J Vision. 2002;2:531-542.
21. Hofer H, Carroll J, Neitz J, et al. Organization of the human trichromatic cone mosaic. J Neurosci. 2005;25:9669-9679.
22. Jacobson SG, Aleman TS, Cideciyan AV, et al. Identifying photoreceptors in blind eyes caused by RPE65 mutations: prerequisite for human gene therapy success. Proc Natl Acad Sci U S A. 2005;102:6177-6182.
23. Ladekjaer-Mikkelsen A-S, Rosenberg T, Jørgensen AL. A new mechanism in blue cone monochromatism. Hum Genet. 1996; 98:403-408.
24. Ueyama H, Muraki-Oda S, Yamade S, et al. Unique haplotype in exon 3 of cone opsin mRNA affects splicing of its precursor, leading to congenital color vision defect. Biochem Biophys Res Commun. 2012;424:152-157.
25. Wagner-Schuman M, Dubis AM, Nordgren RN, et al. Race-and sex-related differences in retinal thickness and foveal pit morphology. Invest Ophthalmol Vis Sci. 2010;52:625-634.
26. Tanna H, Dubis AM, Ayub N, et al. Retinal imaging using commercial broadband optical coherence tomography. Br J Ophthalmol. 2010;94:372-376.
27. Dubra A, Sulai Y. Reflective afocal broadband adaptive optics scanning ophthalmoscope. Biomed Opt Express. 2011;2: 1757-1768.
28. Cooper RF, Dubis AM, Pavaskar A, et al. Spatial and temporal variation of rod photoreceptor reflectance in the human retina. Biomed Opt Express. 2011;2:2577-2589.
29. Gray DC, Merigan W, Wolfing JI, et al. In vivo fluorescence imaging of primate retinal ganglion cells and retinal pigment epithelial cells. Opt Express. 2006;14:7144-7158.
30. ANSI. American National Standard for Safe Use of Lasers (ANSI Z136.1). ANSI Z1361-2007. The Laser Institute of America; 2007.
31. Delori FC, Webb RH, Sliney DH. Institute ANS. Maximum permissible exposures for ocular safety (ANSI 2000), with emphasis on ophthalmic devices. J Opt Soc Am A. 2007;24: 1250-1265.
32. Dubra A, Harvey Z. Registration of 2D images from fast scanning ophthalmic instruments. The 4th International Workshop on Biomedical Image Registration. Lübeck, Germany; 2010.
33. Garrioch R, Langlo C, Dubis AM, et al. Repeatability of in vivo parafoveal cone density and spacing measurements. Optom Vis Sci. 2012;89:632-643.
34. Spaide RF, Curcio CA. Anatomical correlates to the bands seen in the outer retina by optical coherence tomography: literature review and model. Retina. 2011;31:1609-1619.
35. Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with ImageJ. Biophotonics Int. 2004;11:36-42.
36. Williams DR, MacLeod DIA, Hayhoe MM. Punctate sensitivity of the blue-sensitive mechanism. Vision Res. 1981;21:1357-1375.
37. Ahnelt PK, Kolb H, Pflug R. Identification of a subtype of cone photoreceptor, likely to be blue sensitive, in the human retina. J Comp Neurol. 1987;255:18-34.
38. Curcio CA, Allen KA, Sloan KR, et al. Distribution and morphology of human cone photoreceptors stained with anti-blue opsin. J Comp Neurol. 1991;312:610-624.
39. Dubra A, Sulai Y, Norris JL, et al. Non-invasive imaging of the human rod photoreceptor mosaic using a confocal adaptive optics scanning ophthalmoscope. Biomed Opt Express. 2011; 2:1864-1876.
40. Curcio CA, Sloan KR, Kalina RE, Hendrickson AE. Human photoreceptor topography. J Comp Neurol. 1990;292:497-523.
41. Chen Y, Okano K, Maeda T, et al. Mechanism of all-trans-retinal toxicity with implications for stargardt disease and age-related macular degeneration. J Biol Chem. 2012;287:5059-5069.
42. Alexander JJ, Umino Y, Everhart D, et al. Restoration of cone vision in a mouse model of achromatopsia. Nat Med. 2007;13: 685-687.
43. Maguire AM, Simonelli F, Pierce EA, et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med. 2008;358:2240-2248.
44. Bainbridge JW, Smith AJ, Barker SS, et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med. 2008;358:2231-2239.
45. Cideciyan AV, Aleman TS, Boye SL, et al. Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics. Proc Nat Acad Sci U S A. 2008;105:15112-15117.
46. Mancuso K, Hauswirth WW, Li Q, et al. Gene therapy for redgreen colour blindness in adult primates. Nature. 2009;461: 784-787.
47. Komáromy A, Alexander JJ, Rowlan JS, et al. Gene therapy rescues cone function in congenital achromatopsia. Hum Mol Genet. 2010;19:2581-2593.
48. Carvalho LS, Xu J, Pearson R, et al. Long-term and agedependent restoration of visual function in a mouse model of CNGB3-associated achromatopsia following gene therapy. Hum Mol Genet. 2011;20:3161-3175.
49. Talcott KE, Ratnam K, Sundquist S, et al. Longitudinal study of cone photoreceptors during retinal degeneration and in response to ciliary neurotrophic factor treatment. Invest Ophthalmol Vis Sci. 2011;52:2219-2226.